Document 0426 DOCN M9460426 TI Sensitivity of the Papanicolaou smear in human immunodeficiency virus-infected women. DT 9404 AU Korn AP; Autry M; DeRemer PA; Tan W; Department of Obstetrics, Gynecology, and Reproductive Sciences,; University of California, San Francisco. SO Obstet Gynecol. 1994 Mar;83(3):401-4. Unique Identifier : AIDSLINE MED/94173529 AB OBJECTIVE: To determine the sensitivity of the Papanicolaou smear in human immunodeficiency virus (HIV)-infected women. METHODS: Fifty-two HIV-seropositive women underwent colposcopy and had cytologic and histologic specimens obtained. Eighty-five consecutive women seen in our colposcopy clinic who stated that they were HIV-seronegative formed the comparison group. Demographic features of the groups and cytology and histology findings were compared. RESULTS: In HIV-infected patients, the prevalence of cervical dysplasia was 50%. An additional 15% had vulvar lesions alone. The sensitivity of cytologic smears for cervical dysplasia was 63% and specificity was 84%. These findings were not significantly different from those of a control group of women undergoing colposcopy for standard indications (P > .05). Twelve of 38 seropositive women for whom future appointments were scheduled were lost to follow-up. CONCLUSIONS: The sensitivity of the Papanicolaou test does not appear to be diminished in HIV-seropositive women. Screening colposcopy may be justified in view of the high prevalence of cervical and vulvar dysplasia, as well as the high noncompliance rate observed in this patient population. DE Adult Biopsy Cervix Dysplasia/COMPLICATIONS/*PATHOLOGY Female Follow-Up Studies Human HIV Seropositivity/*COMPLICATIONS Predictive Value of Tests Sensitivity and Specificity Support, U.S. Gov't, P.H.S. *Vaginal Smears Vulva/PATHOLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).